Ophthalmic Devices - Greece

  • Greece
  • The projected revenue for the Ophthalmic Devices market market in Greece is estimated to reach US$132.80m by the year 2024.
  • It is expected to exhibit an annual growth rate (CAGR 2024-2029) of 2.89%, leading to a market volume of US$153.10m by 2029.
  • When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$14,000.00m in 2024.
  • Greece is experiencing a surge in demand for ophthalmic devices driven by an aging population and increasing awareness of eye health.

Key regions: Germany, Italy, France, Japan, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Ophthalmic Devices market in Greece has been experiencing steady growth in recent years, driven by customer preferences for advanced technology and the increasing prevalence of eye disorders. Customer preferences in the Ophthalmic Devices market in Greece are shifting towards more advanced and innovative products. With the rapid advancements in technology, customers are seeking devices that offer improved accuracy, precision, and ease of use. They are also looking for devices that offer a wider range of treatment options and customization to suit their individual needs. This preference for advanced technology is driving the demand for ophthalmic devices such as diagnostic and imaging devices, surgical instruments, and vision care products. The increasing prevalence of eye disorders in Greece is another key factor driving the growth of the Ophthalmic Devices market. The aging population, along with lifestyle changes and environmental factors, has contributed to a rise in eye disorders such as cataracts, glaucoma, and macular degeneration. As a result, there is a growing need for ophthalmic devices that can diagnose and treat these conditions effectively. This has led to increased demand for devices such as intraocular lenses, ophthalmic lasers, and surgical instruments. In addition to customer preferences and the prevalence of eye disorders, there are also local special circumstances that are influencing the Ophthalmic Devices market in Greece. The Greek healthcare system has undergone significant reforms in recent years, leading to improved access to healthcare services for the population. This has resulted in increased demand for ophthalmic devices, as more people are able to seek treatment for their eye conditions. Furthermore, Greece has a strong tourism industry, attracting millions of visitors each year. This has created a demand for vision care products such as contact lenses and sunglasses, as tourists seek to protect their eyes and enhance their visual experience while exploring the country. This tourism-driven demand for vision care products is contributing to the growth of the Ophthalmic Devices market in Greece. Underlying macroeconomic factors, such as GDP growth and government healthcare spending, also play a role in the development of the Ophthalmic Devices market in Greece. A stable economy and increased healthcare spending can support the growth of the market by providing the necessary infrastructure and funding for the procurement of ophthalmic devices. Overall, the Ophthalmic Devices market in Greece is experiencing growth due to customer preferences for advanced technology, the increasing prevalence of eye disorders, local special circumstances such as healthcare reforms and tourism, and underlying macroeconomic factors. With these factors driving demand, the market is expected to continue growing in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)